STAT September 12, 2025
Ed Silverman

AbbVie settled litigation in a deal that should prevent U.S. generic versions of Rinvoq until 2037

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, so far, rather modest. We plan to shop for a new tool to help us manicure the Pharmalot grounds, catch up on our reading, possibly enjoy a soiree, and of course, hold a listening party with Mrs. Pharmalot. So far, the rotation will include this, this, this, this and this. And what about you? Summer may be nearing an end but time still remains to enjoy the great outdoors. If weather...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, FDA, Govt Agencies, HHS, Pharma, Pharma / Biotech
FDA guidance eases wearables oversight. But experts have questions about what’s next.
AI Model FDA-Cleared to Triage 14 Conditions
The Promise And Perils Of FDA’s New ‘Plausible Mechanism’ Pathway (Part 2)
FDA Updates Two Digital Health Final Guidance Documents
FDA in Flux — January 2026 Newsletter

Share Article